Cargando…
Serum fibrinopeptide A is increased in patients with acute coronary syndrome
OBJECTIVE: Acute coronary syndrome (ACS) is one of the leading causes of mortality, globally. Atherosclerosis is an underlying factor in ACS process and coagulative cascade is activated secondary to atherosclerotic plaque rupture. Fibrinopeptide A (FPA) takes an active role in thrombus formation and...
Autores principales: | Yilmaz, Ahmet Seyda, Uslu, Abdulkadir, Kara, Faruk, Kahraman, Fatih, Cirakoglu, Omer Faruk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996658/ https://www.ncbi.nlm.nih.gov/pubmed/36910435 http://dx.doi.org/10.14744/nci.2021.12499 |
Ejemplares similares
-
Tolvaptan should be used very carefully in very elderly patients
por: Kahraman, Fatih, et al.
Publicado: (2018) -
Fibrinopeptide
A Family Biomarker Identification at
Single Molecule Level
por: Balme, Sebastien
Publicado: (2023) -
IRAK-4 Variants in acute coronary syndrome patients
por: Ergen, Arzu, et al.
Publicado: (2017) -
Left ventricular steal syndrome caused by multiple plexiform coronary artery fistulae: case report, literature review and treatment
por: Biyik, İsmail, et al.
Publicado: (2016) -
Left Atrial Volume Index to Left Ventricular Ejection Fraction Ratio Predicted Major Adverse Cardiovascular Event in ST-Elevated Myocardial Infarction Patients during 8 Years of Follow-up
por: Yilmaz, Ahmet Seyda, et al.
Publicado: (2021)